Published in Cancer on January 01, 1978
Interferon alfa-2b and chlorambucil in the treatment of non-Hodgkin's lymphoma. Invest New Drugs (1987) 0.76
The management of follicular lymphoma. Drugs (1994) 0.75
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol (1999) 12.42
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat Genet (2000) 8.58
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med (1992) 5.42
All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med (1997) 4.79
Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. N Engl J Med (1982) 3.82
Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg (1993) 3.80
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study. Cancer Res (2001) 3.66
Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol (1990) 3.19
Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. Proc Natl Acad Sci U S A (2001) 3.01
A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol (1985) 2.67
A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B. JAMA (1993) 2.60
ras oncogene activation and occupational exposures in acute myeloid leukemia. J Natl Cancer Inst (1992) 2.54
The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology (2000) 2.51
The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting--Airlie House, Virginia, November, 1997. Hematol J (2000) 2.34
Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res (1998) 2.33
Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med (1975) 2.25
Controversies in transfusion medicine. Prophylactic platelet transfusion therapy: pro. Transfusion (1992) 2.21
Impact of delay in diagnosis on clinical stage of testicular cancer. Lancet (1981) 2.06
T N M classification for stomach cancer. Cancer (1970) 2.03
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11. Cancer Res (1996) 1.99
Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med (1987) 1.94
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experience. Blood (1999) 1.85
Hydroxyurea inhibition of DNA synthesis in ascites tumor. Proc Natl Acad Sci U S A (1965) 1.83
Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol (1989) 1.83
Tamoxifen (antiestrogen) therapy in advanced breast cancer. Ann Intern Med (1977) 1.82
Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect Immun (1999) 1.81
Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet (1996) 1.81
The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia. Proc Natl Acad Sci U S A (1998) 1.79
ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci U S A (1994) 1.74
Psychological symptoms and disease-free and overall survival in women with stage II breast cancer. Cancer and Leukemia Group B. J Natl Cancer Inst (1996) 1.70
Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci U S A (2000) 1.69
Are weight concerns predictive of smoking cessation? A prospective analysis. J Consult Clin Psychol (1997) 1.69
The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol (2000) 1.68
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
Gastric carcinoma: does lymph node dissection alter survival? J Am Coll Surg (1996) 1.62
Morphologic and cytochemical characteristics of acute promyelocytic leukemia. Am J Hematol (1989) 1.54
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations. Cancer Res (1994) 1.54
Clinical importance of cytogenetics in acute myeloid leukaemia. Best Pract Res Clin Haematol (2001) 1.52
ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res (1994) 1.52
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial. J Clin Oncol (1998) 1.51
A novel explosive process is required for the gamma-ray burst GRB 060614. Nature (2006) 1.50
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia. Leukemia (2011) 1.49
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood (1996) 1.49
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemia. Proc Natl Acad Sci U S A (2001) 1.48
Raynaud's phenomenon: a common toxicity after combination chemotherapy for testicular cancer. Ann Intern Med (1981) 1.47
Multidrug resistance in acute myeloid leukemia. J Natl Cancer Inst (1991) 1.45
Hodgkin's disease. CA Cancer J Clin (1994) 1.42
Familial pyrimidinemia and pyrimidinuria associated with severe fluorouracil toxicity. N Engl J Med (1985) 1.41
Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leuk Lymphoma (2009) 1.39
Delphi-panel analysis of appropriateness of high-dose chemotherapy and blood cell or bone marrow autotransplants in diffuse large-cell lymphoma. Leuk Lymphoma (1998) 1.39
Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment. Am J Med (1988) 1.39
Four-drug combination chemotherapy (methotrexate, cyclophosphamide, hexamethylmelamine, and CCNU) for non-small cell bronchogenic carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol (1983) 1.38
Multivariate analysis of prognostic variables in patients with metastatic testicular cancer. Cancer Res (1983) 1.38
Cancer cachexia. Cancer (1979) 1.36
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol (1997) 1.36
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol (1999) 1.36
Report of the Committee on Chromosome Rearrangements in Neoplasia and on Fragile Sites. Cytogenet Cell Genet (1985) 1.36
Effects of season and distance moved during loading on transport losses of market-weight pigs in two commercially available types of trailer. J Anim Sci (2008) 1.34
Stability of HER-2/neu expression over time and at multiple metastatic sites. J Natl Cancer Inst (1993) 1.32
The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin (1992) 1.32
Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin. Cancer (1985) 1.31
Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects. Am J Vet Res (1981) 1.30
All patients with acute nonlymphocytic leukemia may have a chromosomal defect. N Engl J Med (1981) 1.29
Skin changes secondary to hydroxyurea therapy. Arch Dermatol (1975) 1.29
Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med (1978) 1.28
Incidence cytology, and histopathology of non-Hodgkin's lymphomas in the bone marrow. Cancer (1974) 1.27
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood (1994) 1.22
Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation. Blood (1996) 1.21
Blast crisis as an initial or terminal manifestation of chronic myeloid leukemia. A study of 28 patients. Am J Med (1976) 1.21
Morphology and spatial distribution of GABAergic neurons in cat primary auditory cortex (AI). J Comp Neurol (1994) 1.21
Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B Study (8762). Blood (1992) 1.21
Effect of floor space during transport of market-weight pigs on the incidence of transport losses at the packing plant and the relationships between transport conditions and losses. J Anim Sci (2006) 1.20
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol (2001) 1.20
Nodular lymphoma: bone marrow and blood manifestations. Cancer (1975) 1.20
Binding characteristics of zearalenone analogs to estrogen receptors. Cancer Res (1978) 1.18
An altered 11-kilobase transcript in leukemic cell lines with the t(4;11)(q21;q23) chromosome translocation. Cancer Res (1992) 1.18
There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood (1985) 1.18
A controlled trial of prophylactic granulocyte transfusions during initial induction chemotherapy for acute myelogenous leukemia. N Engl J Med (1981) 1.17
Malignant mesothelioma. The University of Minnesota experience. Cancer (1984) 1.17
B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease. J Clin Invest (1973) 1.17
Opportunistic infections in neoplastic diseases. Geriatrics (1970) 1.17
Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy. Cancer Chemother Pharmacol (1987) 1.16
Report of the committee on structural chromosome changes in neoplasia. Cytogenet Cell Genet (1987) 1.15
Mithramycin inhibition of ribonucleic acid synthesis. Cancer Res (1966) 1.15
Hormone therapy for advanced breast cancer. Cancer (1965) 1.14
Nonrandom chromosome abnormalities in lymphoma. Cancer Res (1983) 1.14
Selective interaction of peripheral and central nervous system cells with two distinct cell-binding domains of fibronectin. J Cell Biol (1987) 1.13